期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Cytotoxicity of fullerenols on Tetrahymena pyriformis 被引量:1
1
作者 ZHAO Qun-Fen ZHU Ying +3 位作者 ran tie-cheng LI Jun-Gang LI Qing-Nuan LI Wen-Xin 《Nuclear Science and Techniques》 SCIE CAS CSCD 2006年第5期280-284,共5页
With the increasing use of fullerenes and their derivatives in a variety of fields, the toxicity and effects of fullerenes on humans and the environment have received considerable attention. In this study, the cytotox... With the increasing use of fullerenes and their derivatives in a variety of fields, the toxicity and effects of fullerenes on humans and the environment have received considerable attention. In this study, the cytotoxicity of fullerene derivative, C60(OH)x, on Tetrahymena pyriformis was investigated. Cell growth inhibition was evaluated by counting with an optical microscope, and the generation time was calculated. It was indicated that the fullerenols caused a dose-dependent growth inhibition of the cells. The morphologic change in the damaged macronucleus of cells was observed using a fluorescent microscope. Superoxide dismutase (SOD), glutathione peroxidase (GSH-PX), and glutathione reductase (GR) levels were also measured for Tetrahymena pyriformis, using conventional methods. The results showed that fullerenols could reduce GSH-PX and GR activities. But no noticeable difference in SOD ac- tivity was observed between the treated groups and the control group. This indicated that the antiproliferative effect of fullerenols might be mediated by the reduction in the activities of GSH-PX and GR of cells and the destruction of the macronucleus. 展开更多
关键词 细胞毒性 四膜虫属梨状肌 富勒醇 过氧化物歧化酶 谷胱甘肽过氧化酶
下载PDF
静注人免疫球蛋白产品中活化Ⅺ因子活性凝血酶生成试验检测方法的建立
2
作者 易佳炜 程露 +1 位作者 冉铁成 徐俊 《中国生物制品学杂志》 CAS CSCD 2019年第2期211-214,共4页
目的建立静注人免疫球蛋白(intravenous immunoglobulin,IVIG)中活化Ⅺ因子(activated factorⅪ,FⅪa)活性凝血酶生成试验(thrombin generation assay,TGA)的测定方法。方法采用自动校正凝血酶生成(calibrated automated thrombogram,C... 目的建立静注人免疫球蛋白(intravenous immunoglobulin,IVIG)中活化Ⅺ因子(activated factorⅪ,FⅪa)活性凝血酶生成试验(thrombin generation assay,TGA)的测定方法。方法采用自动校正凝血酶生成(calibrated automated thrombogram,CAT)分析仪,建立IVIG中FⅪa活性检测方法,并确定方法的线性范围和检测限,验证方法的精密度和准确性。采用建立的方法对4家血液制品公司的29批IVIG产品进行FⅪa活性定量测定。结果 FⅪa浓度在3. 34~27. 84 mIU/mL范围时,与凝血酶峰值浓度(peak thrombin concentration,PTC)呈良好的线性关系,回归方程为Y=-0. 022 8 X^2+1. 891 6 X+10. 282,R^2=0. 989;检测限为2. 76 mIU/mL;供试品的6次测定结果 RSD为12. 9%;低、中、高浓度加标样品的回收率分别为86. 7%、116. 7%、121. 6%,RSD分别为16. 4%、19. 8%、8. 4%。29批IVIG产品中,不同厂家及相同厂家不同批次间FⅪa活性均存在一定差异。结论建立了用于检测IVIG产品中FⅪa活性的TGA方法,且具有良好的线性、精密性及准确性,可用于评价IVIG产品的致血栓风险。 展开更多
关键词 静注人免疫球蛋白 活化Ⅺ因子 凝血酶生成试验
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部